These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1314873)

  • 1. Sodium stibogluconate (Pentostam) overdose during treatment of American cutaneous leishmaniasis.
    Herwaldt BL; Kaye ET; Lepore TJ; Berman JD; Baden HP
    J Infect Dis; 1992 May; 165(5):968-71. PubMed ID: 1314873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
    Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF
    J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis.
    Hepburn NC; Tidman MJ; Hunter JA
    Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of pentostam (sodium stibogluconate) against cutaneous leishmaniasis in mice treated with neutralizing anti-interferon-gamma antibody.
    Nabors GS; Farrell JP
    Am J Trop Med Hyg; 1995 Jul; 53(1):55-60. PubMed ID: 7625533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-patient parenteral antimicrobial therapy--a viable option for the management of cutaneous leishmaniasis.
    Seaton RA; Morrison J; Man I; Watson J; Nathwani D
    QJM; 1999 Nov; 92(11):659-67. PubMed ID: 10542306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers.
    Solomon M; Pavlotzky F; Barzilai A; Schwartz E
    J Am Acad Dermatol; 2013 Feb; 68(2):284-9. PubMed ID: 22858005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya.
    Chulay JD; Anzeze EM; Koech DK; Bryceson AD
    Trans R Soc Trop Med Hyg; 1983; 77(5):717-21. PubMed ID: 6318408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster virus meningitis complicating sodium stibogluconate treatment for cutaneous leishmaniasis.
    Hartzell JD; Aronson NE; Nagaraja S; Whitman T; Hawkes CA; Wortmann G
    Am J Trop Med Hyg; 2006 Apr; 74(4):591-2. PubMed ID: 16606989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case 4-2005: sodium stibogluconate for cutaneous leishmaniasis.
    Hartzell JD; Aronson N
    N Engl J Med; 2005 May; 352(18):1929. PubMed ID: 15872214
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis.
    Soto J; Valda-Rodriquez L; Toledo J; Vera-Navarro L; Luz M; Monasterios-Torrico H; Vega J; Berman J
    Am J Trop Med Hyg; 2004 Nov; 71(5):577-81. PubMed ID: 15569787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic Effect Of Oral Allopurinol And Intralesional Sodium Stibogluconate In The Treatment Of Cutaneous Leishmaniasis.
    Rashid HU; Ullah I; Adeeb H; Zeb M; Mohammad A; Rehman N
    J Ayub Med Coll Abbottabad; 2020; 32(4):558-561. PubMed ID: 33225663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application].
    Henao HH; Osorio Y; Saravia NG; Gómez A; Travi B
    Biomedica; 2004 Dec; 24(4):393-402. PubMed ID: 15678803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis.
    Wortmann GW; Aronson NE; Byrd JC; Grever MR; Oster CN
    Clin Infect Dis; 1998 Sep; 27(3):509-12. PubMed ID: 9770149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with New World cutaneous leishmaniasis in travelers.
    Scope A; Trau H; Anders G; Barzilai A; Confino Y; Schwartz E
    J Am Acad Dermatol; 2003 Oct; 49(4):672-8. PubMed ID: 14512915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis.
    Ballou WR; McClain JB; Gordon DM; Shanks GD; Andujar J; Berman JD; Chulay JD
    Lancet; 1987 Jul; 2(8549):13-6. PubMed ID: 2885505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate.
    Martinez S; Gonzalez M; Vernaza ME
    Clin Infect Dis; 1997 Feb; 24(2):165-9. PubMed ID: 9114142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate.
    Solomon M; Baum S; Barzilai A; Pavlotsky F; Trau H; Schwartz E
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1189-92. PubMed ID: 19298486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam).
    Kellum RE
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):620-2. PubMed ID: 3021826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.